• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经静脉植入式心脏电子设备与血液透析导管:减少潜在致命组合的建议。

Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination.

作者信息

Asif Arif, Salman Loay, Lopera Gustavo, Haqqie Syed S, Carrillo Roger

机构信息

Interventional Nephrology, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.

出版信息

Semin Dial. 2012 Sep-Oct;25(5):582-6. doi: 10.1111/j.1525-139X.2012.01053.x. Epub 2012 Feb 22.

DOI:10.1111/j.1525-139X.2012.01053.x
PMID:22353033
Abstract

Abnormal renal function is an independent risk factor for cardiac implantable electronic device (CIED) infection. The risk of CIED infection increases as the degree of renal dysfunction worsens with the highest risk observed in patients with stage V chronic kidney disease. A significant portion of these patients use a tunneled hemodialysis catheter (TDC) for dialysis therapy. These devices are associated with very high rates of catheter-related bacteremia (1.6-5.5 episodes of bacteremia per 1000 catheter days), and have been known to cause infection of CIED indwelling in the bloodstream. In this context, the cardiac device is exposed to the risk of infection due to the presence of renal failure and episodes of bacteremia related to TDCs. Both increase the risk of CIED infection. Once infected, a cardiac rhythm device carries a marked increase in morbidity and mortality. In this context, the combination of a TDC and a CIED indwelling in the bloodstream becomes a potentially deadly combination. Recent data have emphasized that epicardial CIED implantation reduces cardiac device infection in TDC patients. This report highlights the risk of CIED infection in renal patients, presents TDC's contribution to the cardiac device infection, and suggests recommendations to minimize the risk of CIED infection in chronic hemodialysis patients dialyzing with a TDC.

摘要

肾功能异常是心脏植入式电子设备(CIED)感染的独立危险因素。随着肾功能不全程度的加重,CIED感染风险增加,其中V期慢性肾脏病患者的风险最高。这些患者中有很大一部分使用带隧道的血液透析导管(TDC)进行透析治疗。这些设备与极高的导管相关菌血症发生率相关(每1000导管日发生1.6 - 5.5次菌血症),并且已知会导致血流中CIED感染。在这种情况下,由于存在肾衰竭以及与TDC相关的菌血症发作,心脏设备面临感染风险。这两者都会增加CIED感染的风险。一旦感染,心脏节律设备的发病率和死亡率会显著增加。在这种情况下,TDC与血流中留置的CIED相结合成为一种潜在的致命组合。最近的数据强调,心外膜CIED植入可降低TDC患者的心脏设备感染率。本报告强调了肾病患者发生CIED感染的风险,介绍了TDC对心脏设备感染的影响,并提出了将使用TDC进行慢性血液透析患者的CIED感染风险降至最低的建议。

相似文献

1
Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination.经静脉植入式心脏电子设备与血液透析导管:减少潜在致命组合的建议。
Semin Dial. 2012 Sep-Oct;25(5):582-6. doi: 10.1111/j.1525-139X.2012.01053.x. Epub 2012 Feb 22.
2
Epicardial cardiac rhythm devices for dialysis patients: minimizing the risk of infection and preserving central veins.用于透析患者的心外膜心脏节律装置:将感染风险降至最低并保护中心静脉。
Semin Dial. 2012 Jan-Feb;25(1):88-94. doi: 10.1111/j.1525-139X.2010.00757.x. Epub 2010 Aug 27.
3
Contamination of transvenous pacemaker leads due to tunneled hemodialysis catheter infection: a report of 2 cases.经隧道式血液透析导管感染导致经静脉起搏器导线污染:2 例报告。
Am J Kidney Dis. 2010 Jun;55(6):1097-101. doi: 10.1053/j.ajkd.2010.01.009. Epub 2010 Apr 3.
4
Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia.金黄色葡萄球菌菌血症患者的心血管植入式电子设备感染
Pacing Clin Electrophysiol. 2010 Apr;33(4):407-13. doi: 10.1111/j.1540-8159.2009.02565.x. Epub 2009 Sep 30.
5
Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study.心脏植入式电子设备感染后的长期结局:一项前瞻性匹配队列研究。
Heart. 2012 May;98(9):724-31. doi: 10.1136/heartjnl-2012-301627.
6
Management of bacteremia in patients living with cardiovascular implantable electronic devices.心血管植入式电子装置植入患者的菌血症管理
Heart Rhythm. 2016 Nov;13(11):2247-2252. doi: 10.1016/j.hrthm.2016.08.029. Epub 2016 Aug 19.
7
Prevalence of chronic kidney disease in patients undergoing cardiac rhythm device removal.接受心律装置移除术患者的慢性肾脏病患病率
Semin Dial. 2013 Jan-Feb;26(1):111-3. doi: 10.1111/j.1525-139X.2012.01101.x. Epub 2012 Jul 11.
8
Contemporary management of cardiovascular implantable electronic device infections.心血管植入电子设备感染的当代管理。
Expert Rev Anti Infect Ther. 2010 Jul;8(7):831-9. doi: 10.1586/eri.10.54.
9
The dilemma of transvenous cardiac rhythm devices in hemodialysis patients: time to consider the epicardial approach?血液透析患者经静脉心脏节律装置的困境:是时候考虑心外膜途径了吗?
Kidney Int. 2011 Jun;79(12):1267-9. doi: 10.1038/ki.2011.53.
10
Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice.慢性肾脏病和终末期肾病患者的心血管植入式电子设备导线:综述与实践建议
Semin Dial. 2013 Jan-Feb;26(1):114-23. doi: 10.1111/j.1525-139X.2012.01103.x. Epub 2012 Aug 15.

引用本文的文献

1
Subcutaneous versus Transvenous Implantable Cardioverter Defibrillator in Patients with End-Stage Renal Disease Requiring Dialysis: Extended Long-Term Retrospective Multicenter Follow-Up.终末期肾病需要透析患者皮下与经静脉植入式心律转复除颤器:长期回顾性多中心随访扩展研究
J Pers Med. 2024 Aug 17;14(8):870. doi: 10.3390/jpm14080870.
2
Comparison of infection and complication rates associated with transvenous vs. subcutaneous defibrillators in patients with stage 4 chronic kidney disease: a multicenter long-term retrospective follow-up.4期慢性肾病患者经静脉与皮下植入式心脏除颤器相关感染和并发症发生率的比较:一项多中心长期回顾性随访研究
Front Cardiovasc Med. 2024 Apr 10;11:1397138. doi: 10.3389/fcvm.2024.1397138. eCollection 2024.
3
Do Implantable Cardioverter-Defibrillators Prevent Sudden Cardiac Death in End-Stage Renal Disease Patients on Dialysis?植入式心脏复律除颤器能否预防终末期肾病透析患者的心源性猝死?
J Clin Med. 2024 Feb 19;13(4):1176. doi: 10.3390/jcm13041176.
4
Subcutaneous cardioverter defibrillator implanted intermuscularly in patients with end-stage renal disease requiring hemodialysis: 5-year follow-up.终末期肾病需血液透析患者肌肉内植入皮下心脏复律除颤器:5年随访
J Interv Card Electrophysiol. 2024 Feb 22. doi: 10.1007/s10840-024-01767-1.
5
Pacemaker leads as a potential source of problems in patients who might need a central venous access port.对于可能需要中心静脉通路端口的患者,起搏器导线可能是问题的一个潜在来源。
Cardiovasc Diagn Ther. 2023 Dec 15;13(6):1068-1079. doi: 10.21037/cdt-23-104. Epub 2023 Oct 27.
6
How does a CIED presence influence chances and safety of haemodialysis access? Conclusions from over 3000 thoracic venografies.心脏植入式电子设备的存在如何影响血液透析通路的建立机会和安全性?3000 多次胸部静脉造影的结论。
Clin Physiol Funct Imaging. 2023 Jan;43(1):47-57. doi: 10.1111/cpf.12792. Epub 2022 Oct 28.
7
Cardiac Implantable Electronic Devices in Hemodialysis and Chronic Kidney Disease Patients-An Experience-Based Narrative Review.血液透析和慢性肾脏病患者的心脏植入式电子设备——基于经验的叙述性综述
J Clin Med. 2021 Apr 17;10(8):1745. doi: 10.3390/jcm10081745.
8
Implantable Cardioverter-Defibrillators in Patients with ESRD: Complications, Management, and Literature Review.终末期肾病患者的植入式心脏复律除颤器:并发症、管理及文献综述
Curr Cardiol Rev. 2019;15(3):161-166. doi: 10.2174/1573403X15666190118123754.
9
Impact of transvenous cardiac implantable electronic devices in chronic hemodialysis patients: a single-center, observational comparative study.经静脉植入式心脏电子设备对慢性血液透析患者的影响:一项单中心观察性比较研究。
BMC Nephrol. 2018 Oct 20;19(1):281. doi: 10.1186/s12882-018-1095-y.
10
Systemic infection due to subcutaneous implantable cardioverter-defibrillator implantation: Importance of early recognition and treatment of device pocket-related complications.皮下植入式心律转复除颤器植入导致的全身感染:早期识别和治疗与设备囊袋相关并发症的重要性。
HeartRhythm Case Rep. 2016 Sep 28;3(1):40-42. doi: 10.1016/j.hrcr.2016.08.014. eCollection 2017 Jan.